PHASTAR AND COVID-19
Working together during COVID-19
At PHASTAR, we understand the urgency of getting the COVID-19 global pandemic under control as quickly and as safely as possible.
In terms of our staff, we have taken steps to allow all our global staff to work from home, supported by enhanced server capabilities. Our systems allow for uninterrupted, effective remote working and staff are in continued contact with each other via video conferences and phone calls. Furthermore, in line with WHO and local governmental guidelines all business travel has been suspended until further notice.
PHASTAR is currently working on several COVID-19 projects including vaccine, diagnostic and antibody trials. We continue to be available to discuss modifications of trials in light of the current situation and can help with any aspect of your trial from rapid database development, efficient clinical trial design/ review and communicating with regulatory agencies. We understand that every trial will have its own individual challenges arising from this pandemic and our team are on hand to discuss any of your concerns.
PHASTAR is able to assist through our statistical consulting, statistical programming, data management or data science capabilities.